UCalgary’s Cyber Assessment, Training and Experimentation Centre opens; the Canadian Space Agency funds research on health in space, and Ottawa and Manitoba invest in the animal health lab information management system to prepare for new and emerging animal diseases in the province.
Topic: Canadian biomanufacturing
The Short Report – March 2, 2022: Ottawa commits $240M for semiconductor industry, $45M for post-secondary research infrastructure, a good month for the space sector, and more
Ottawa calls for “ambitious, transformative proposals” in manufacturing capacity as it boosts the semiconductor ecosystem, Canada’s post-secondary institutes receive $45 million for research infrastructure support, Canadian aerospace companies earn lucrative contracts, and more.
The Short Report – Dec. 8, 2021: Ontario launches flagship EV program, Alberta boosts vaccine development capacity, applied research on the rise, and more
The launch of Ontario’s vehicle innovation network signals readiness for next-generation auto solutions, Alberta invests tens of millions of dollars to fund vaccine research and manufacturing capacity, research activity continues to grow at colleges and institutes across Canada, and more.
The Short Report – Sept. 15, 2021: COVID-19’s financial impact on universities, boosting biotherapeutics manufacturing, and more
A new biomanufacturing partnership will boost Canada’s manufacturing capacity, projecting pandemic-induced revenue loss for Canada’s universities, IPIC makes pre-budget recommendations, and more.
The Short Report – August 4, 2021: Ottawa’s new biomanufacturing and life sciences strategy, a national startup job board, rural transit solutions, and more
Ottawa prepares for future pandemics with launch of life science strategy, CellCAN and CCRM launch a new cell and gene therapy institute to tackle gaps in training, a new fund dedicated to developing transit solutions for rural and remote communities, and more.
The Short Report – June 23, 2021: Construction finishes on Biologic’s vaccine plant, a new interdisciplinary school of health at Concordia, quantum research funding in Quebec and more
Minister Champagne announces construction of NRC’s vaccine plant in Montreal is complete, Concordia gets go-ahead for a new school of interdisciplinary health, NISC receives quantum research funding to improve online communication security, and more.
The Short Report – May 19, 2021: Ottawa injects $200 million into domestic vaccine manufacturing capacity, CAN Health Network project extended, nuclear leaders prepare CANDU reactors for decommissioning, and more
Resilience Biotechnologies receives significant funding to produce made-in-Canada vaccines, Ottawa extends the CAN Health Network project in Ontario by one year with a $3.25-million investment, Canada’s nuclear leaders collaborate on the decommissioning process, and more.
Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics
The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.